Indication:Asmanex HFA is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older.

Insight:

Dosing: In patients 12 years of age and older, 2 inhalations twice daily of Asmanex HFA 100 mcg or 200 mcg.
Dosage forms: Inhalation aerosol containing 100 mcg or 200 mcg of mometasone furoate per actuation.
Adverse events: Most common adverse reactions reported in greater than or equal to 3% of patients included nasopharyngitis, headache, sinusitis, bronchitis, and influenza.
Mechanism of action: Mometasone furoate is a corticosteroid demonstrating potent anti-inflammatory activity.
Manufacturer: Merck

Sources:

label (fda.gov)
asmanex image - Google Search